Conference attendance
Company Type
Index
Countries
Reset

Deloitte AG

Company Type
Private
Sector
Colin Terry
Colin Terry
Partner, R&D Strategy and Operations 
Conference attendance
MTDH
Biography

Colin is a Director and a key leader in our UK / Swiss Life Science practice. He has been with Deloitte since 2011 working in the US firm until 2014 when he moved to the UK.

Colin’s client advisory work in the Life Sciences sector ranges across strategy and operations focused on the R&D function including operating model development and implementation as well as post-merger integration (PMI). These engagements have been serving client Boards and their senior leadership teams in R&D, Commercial and Supply Chain

Colin is an author of our annual R&D productivity analysis study which reviews productivity of the worlds largest pharmaceutical businesses.

Recent engagements include leadership of the R&D integration workstream for a Med Tech merger leading the European team as well as global responsibility for the R&D and Manufacturing footprints; and design of a new Pharma vaccine R&D model post integration

Colin has a B.Sc (Hons). in Microbiology from the University of London, Queen Mary & Westfield and a Marketing Diploma from the Chartered Institute of Marketing. 

Murielle Launay
Senior Manager 
Conference attendance
MTDH
Mrs Anna Samanta
Mrs Anna Samanta
Managing Partner 
Conference attendance
MTDH
Biography

Anna leads Deloitte’s Integration & Separation Advisory (I&SA) team in Switzerland and the EMEA Centre of Excellence for Life Sciences I&SA. Anna is recognized as one of the foremost integration advisors in EMEA and has supported over 30 integrations and separations including many landmark deals. She provides advice and challenge to senior management and boards in planning and delivering complex cross-border integrations and operational carve outs.

John Feigl
Head of Debt & Rating Advisory Switzerland 
Conference attendance
MTDH
Nico Kleyn
Partner 
Conference attendance
MTDH

Drooms AG

Drooms is the leading provider of data rooms in Europe. The specialized software facilitates highly secure access to confidential documents, as well as the ability to exchange them safely with third parties beyond company firewalls. Drooms allows for the transparent, efficient and secure management of confidential business processes such as commercial real estate sales, mergers and acquisitions, NPL transactions and board communications. Drooms’ clients include the world's leading real estate companies, consulting and law firms and corporations such as METRO GROUP, Evonik, Morgan Stanley, JLL, JP Morgan, CBRE, Rewe and UBS.

Website:
https://www.drooms.com/
Company Type
Private
Sector
Jan Hoffmeister
Managing Director 
Conference attendance
MTDH & BEF
Luisa Henk
Luisa Henk
Senior Manager Business Development 
Conference attendance
MTDH & BEF

Novasecta Ltd. United Kingdom

Novasecta is a specialist management consulting firm for pharmaceutical companies. Novasecta’s clients are primarily CEOs, Commercial Heads and R&D Heads. We provide them with practical solutions based on a profound understanding of their unique businesses and their industry context. We deliver the strategic counsel, insight, and change that they need to drive performance improvement and sustainable growth.

Website:
http://www.novasecta.com
Company Type
Private
Sector
Keywords

Strategy

Business Development

R&D

Commercial

CEO

Consulting

Mr John Rountree
Mr John Rountree
Managing Partner 
Conference attendance
BEF
Biography

John has over 30 years of experience in management consulting and creating value with pharmaceutical and medical product companies.

He founded Novasecta in 2003 and has built the company by selecting and developing top quality consultants who work successfully with clients across R&D, corporate/business development and commercial disciplines. John has directed many strategic and management initiatives, achieving amongst others, strategic organisational change, major licensing deals, corporate transformation, optimised asset portfolios, and improvements in strategic partnerships.